Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics - Salarius Pharmaceuticals (NA
英伟达(US:NVDA) Benzinga·2026-01-07 21:45Trading under DCOY to commence on January 8, 2026Company's proprietary peptide-conjugate platform leverages AI-enabled computational infrastructure to accelerate candidate selectionCapital-efficient 2026 plan features advancing lead antiviral into the clinic while expanding pipeline and partnership opportunitiesCAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) (Salarius) announces it will change its corporate name to Decoy Therapeutics Inc. (Decoy) and its comm ...